TAVARES LINO,REIDENBERG BRUCE E.,SACKLER RICHARD S.,WRIGHT CURTIS,ALFONSO MARK A.,OSHLACK BENJAMIN,CASSIDY JAMES P.,CARPANZANO ANTHONY E.,GULLAPALLI RAMPURNA PRASAD,SHEVCHUK IHOR
申请号：
SI200230970
公开号：
SI2062573T1
申请日:
2002.04.30
申请国别(地区):
SI
年份:
2012
代理人:
摘要：
The present invention relates to transdermal dosage form ( Fig. 1-3 ) comprising at least one activating agent and at least one inactivating agent. The dosage form ( Fig. 1-3 ) releases the inactivating agent upon disruption of the dosage form ( Fig. 1-3 ) thereby preventing or hindering misuse of the active agent contained in the dosage form ( Fig. 1-3 ).
